Should we target "intermediate expression" of HER2 in older estrogen receptor positive patients?

ABSTRACT:

SUBMITTER: Tokumaru Y 

PROVIDER: S-EPMC7580860 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature